These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
732 related items for PubMed ID: 16818533
21. What is the current role for parenteral lipid emulsions containing omega-3 fatty acids in infants with short bowel syndrome? Diamond IR, Pencharz PB, Wales PW. Minerva Pediatr; 2009 Jun; 61(3):263-72. PubMed ID: 19461570 [Abstract] [Full Text] [Related]
22. Use of an omega-3 fatty acid-based emulsion in the treatment of parenteral nutrition-induced cholestasis in patients with microvillous inclusion disease. Fuchs J, Fallon EM, Gura KM, Puder M. J Pediatr Surg; 2011 Dec; 46(12):2376-82. PubMed ID: 22152886 [Abstract] [Full Text] [Related]
23. Effect of omega-3 polyunsaturated fatty acids to reverse biopsy-proven parenteral nutrition-associated liver disease in adults. Xu Z, Li Y, Wang J, Wu B, Li J. Clin Nutr; 2012 Apr; 31(2):217-23. PubMed ID: 22035955 [Abstract] [Full Text] [Related]
24. Improved outcomes in paediatric intestinal failure with aggressive prevention of liver disease. Sigalet D, Boctor D, Robertson M, Lam V, Brindle M, Sarkhosh K, Driedger L, Sajedi M. Eur J Pediatr Surg; 2009 Dec; 19(6):348-53. PubMed ID: 19866409 [Abstract] [Full Text] [Related]
25. Fish oil-based lipid emulsions prevent and reverse parenteral nutrition-associated liver disease: the Boston experience. de Meijer VE, Gura KM, Le HD, Meisel JA, Puder M. JPEN J Parenter Enteral Nutr; 2009 Dec; 33(5):541-7. PubMed ID: 19571170 [Abstract] [Full Text] [Related]
26. Pediatric parenteral nutrition-associated liver disease and cholestasis: Novel advances in pathomechanisms-based prevention and treatment. Orso G, Mandato C, Veropalumbo C, Cecchi N, Garzi A, Vajro P. Dig Liver Dis; 2016 Mar; 48(3):215-22. PubMed ID: 26698410 [Abstract] [Full Text] [Related]
27. High rates of resolution of cholestasis in parenteral nutrition-associated liver disease with fish oil-based lipid emulsion monotherapy. Premkumar MH, Carter BA, Hawthorne KM, King K, Abrams SA. J Pediatr; 2013 Apr; 162(4):793-798.e1. PubMed ID: 23164314 [Abstract] [Full Text] [Related]
28. Reversal of parenteral nutrition-associated liver disease with a fish oil-based lipid emulsion (Omegaven) in an adult dependent on home parenteral nutrition. Burns DL, Gill BM. JPEN J Parenter Enteral Nutr; 2013 Mar; 37(2):274-80. PubMed ID: 22683685 [Abstract] [Full Text] [Related]
29. Early enteral fat supplementation with microlipid® and fish oil in the treatment of two premature infants with short bowel. Yang Q, Welch CD, Ayers K, Turner C, Pranikoff T. Neonatology; 2010 Mar; 98(4):348-53. PubMed ID: 20980771 [Abstract] [Full Text] [Related]
30. Parenteral fish oil as monotherapy improves lipid profiles in children with parenteral nutrition-associated liver disease. Le HD, de Meijer VE, Zurakowski D, Meisel JA, Gura KM, Puder M. JPEN J Parenter Enteral Nutr; 2010 Mar; 34(5):477-84. PubMed ID: 20852175 [Abstract] [Full Text] [Related]
31. Improvement in Parenteral Nutrition-Associated Cholestasis With the Use of Omegaven in an Infant With Short Bowel Syndrome. Strang BJ, Reddix BA, Wolk RA. Nutr Clin Pract; 2016 Oct; 31(5):647-53. PubMed ID: 27143651 [Abstract] [Full Text] [Related]
32. Safety and efficacy of a lipid emulsion containing a mixture of soybean oil, medium-chain triglycerides, olive oil, and fish oil: a randomised, double-blind clinical trial in premature infants requiring parenteral nutrition. Tomsits E, Pataki M, Tölgyesi A, Fekete G, Rischak K, Szollár L. J Pediatr Gastroenterol Nutr; 2010 Oct; 51(4):514-21. PubMed ID: 20531018 [Abstract] [Full Text] [Related]
33. Effect of a fish oil-based lipid emulsion on intestinal failure-associated liver disease in children. Zhang T, Wang N, Yan W, Lu L, Tao Y, Li F, Wang Y, Cai W. Eur J Clin Nutr; 2018 Oct; 72(10):1364-1372. PubMed ID: 29382923 [Abstract] [Full Text] [Related]
35. Preservation of biochemical liver function with low-dose soy-based lipids in children with intestinal failure-associated liver disease. Khan FA, Fisher JG, Sparks EA, Potemkin A, Duggan C, Raphael BP, Modi BP, Jaksic T. J Pediatr Gastroenterol Nutr; 2015 Mar; 60(3):375-7. PubMed ID: 25714580 [Abstract] [Full Text] [Related]
36. Prevention of parenteral nutrition-associated liver disease: role of omega-3 fish oil. Fallon EM, Le HD, Puder M. Curr Opin Organ Transplant; 2010 Jun; 15(3):334-40. PubMed ID: 20503524 [Abstract] [Full Text] [Related]
37. Rapid infusion of fish oil-based emulsion in infants does not appear to be associated with fat overload syndrome. Gura KM, Puder M. Nutr Clin Pract; 2010 Aug; 25(4):399-402. PubMed ID: 20702846 [Abstract] [Full Text] [Related]
38. Effect of parenteral fish oil lipid emulsion in parenteral nutrition supplementation combined with enteral nutrition support in patients undergoing pancreaticoduodenectomy. Zhu X, Wu Y, Qiu Y, Jiang C, Ding Y. JPEN J Parenter Enteral Nutr; 2013 Mar; 37(2):236-42. PubMed ID: 22699972 [Abstract] [Full Text] [Related]
39. [Use of fish oil lipid emulsions in hospitalized patients under 18 years old with abnormal results in liver tests associated with total parental nutrition]. Giraldo Villa A, Henao Roldan C, García Loboguerrero F, Martínez Volkmar MI, Contreras Ramírez MM, Ruiz Navas P, Grupo de Soporte Nutricional Pediátrico. Hospital Pablo Tobón Uribe. Nutr Hosp; 2014 Apr 01; 29(4):844-51. PubMed ID: 24679026 [Abstract] [Full Text] [Related]
40. Superiority of a fish oil-enriched emulsion to medium-chain triacylglycerols/long-chain triacylglycerols in gastrointestinal surgery patients: a randomized clinical trial. Wang J, Yu JC, Kang WM, Ma ZQ. Nutrition; 2012 Jun 01; 28(6):623-9. PubMed ID: 22113064 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]